Vaccines

Vaccines is an international, peer-reviewed, open access journal published monthly online by MDPI. The American Society for Virology (ASV) is affiliated with Vaccines and their members receive a discount on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
  • Journal Rank: JCR - Q1 (Immunology) / CiteScore - Q1 (Pharmacology (medical))
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 19.2 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the second half of 2023).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor: 7.8 (2022); 5-Year Impact Factor: 7.4 (2022)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Diseases, IJMS, Microbiology Research, Pathogens, Vaccines
Advances in Human Pathogen Control—a 21st Century Challenge 2.0 Topic Editors: Jorge H. Leit?o, Nitin Amdare, Joana R Feliciano
Deadline: 30 June 2024
Topic in Cells, Diseases, Healthcare, IJMS, Vaccines
Inflammation: The Cause of all Diseases 2.0 Topic Editors: Vasso Apostolopoulos, Jack Feehan, Vivek P. Chavda
Deadline: 31 July 2024
Topic in Biomedicines, JCM, Pathogens, Vaccines, Viruses
Discovery and Development of Monkeypox Disease Treatments Topic Editors: Mohd Imran, Ali A. Rabaan
Deadline: 31 August 2024
Topic in Brain Sciences, Clinics and Practice, COVID, Life, Vaccines, Viruses
Multifaceted Efforts from Basic Research to Clinical Practice in Controlling COVID-19 Disease Topic Editors: Yih-Horng Shiao, Rashi Ojha
Deadline: 30 September 2024
Special Issue in Vaccines
Advances in the Use of Nanoparticles for Vaccine Platform Development Guest Editor: Imran Saleem
Deadline: 20 April 2024
Special Issue in Vaccines
Public Psychobehavioral Responses towards Vaccination Guest Editor: Li Ping Wong
Deadline: 30 April 2024
Special Issue in Vaccines
Novel Vaccines for Infectious Pathogens Guest Editors: Veerupaxagouda Patil, Dhruv Desai
Deadline: 20 May 2024
Special Issue in Vaccines
COVID-19 Vaccine Acceptance and Uptake: Insights from Behavioural and Social Sciences Guest Editor: Christian Napoli
Deadline: 31 May 2024
Topical Collection in Vaccines
COVID-19 Vaccine Hesitancy: Correlates and Interventions Collection Editors: Manoj Sharma, Kavita Batra
Topical Collection in Vaccines
Topic Advisory Panel Members’ Collection Series: Immunization and Vaccines for Infectious Diseases Collection Editors: Shumaila Hanif, Ravinder Kumar
Topical Collection in Vaccines
HPV-Vaccines Collection Editor: Gloria Calagna
Topical Collection in Vaccines
Research on Monoclonal Antibodies and Antibody Engineering Collection Editor: Tatsuya Yamazaki
Back to TopTop
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news